Madrigal Pharmaceuticals Stock Price - MDGL

Best deals to access real time data!
CHART Trader
Monthly Subscription
for only
$30.66
Canadian Level 1 + USA
Monthly Subscription
for only
$38.05
Small Cap Basic
Monthly Subscription
for only
$33.03
VAT not included
Company Name Stock Ticker Symbol Market Type
Madrigal Pharmaceuticals Inc MDGL NASDAQ Common Stock
  Price Change Change Percent Stock Price High Price Low Price Open Price Close Price Last Traded
  -3.16 -3.04% 100.65 103.34 100.00 102.88 103.81 11:20:47
Bid Price Ask Price Spread Spread % News
100.67 101.11 0.44 0.44% - -
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
573 39,982 $ 101.64 $ 4,063,862 127,413 82.31 - 153.60
Last Trade Time Type Quantity Stock Price Currency
11:19:17 19 $ 100.95 USD

Madrigal Pharmaceuticals Financials

Market Cap Shares in Issue Profit/Loss Earnings Per Share (EPS) PE Ratio Float
$ 1.56B 15.43M $ -32.81M -2.22 - 6.71M
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% - -

more financials information »

Madrigal Pharmaceuticals News

Date Time Source News Article
11/11/201917:30GlobeNewswire Inc.Madrigal Pharmaceuticals Announces Publication in The Lancet..
11/06/201908:32Edgar (US Regulatory)Current Report Filing (8-k)
11/06/201906:50GlobeNewswire Inc.Madrigal Pharmaceuticals Reports 2019 Third Quarter..
11/06/201906:07Edgar (US Regulatory)Quarterly Report (10-q)
10/17/201915:47Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)
10/17/201915:46Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)
10/17/201915:45Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)

Latest MDGL Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical MDGL Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week92.83109.03591.54102.67141,9807.828.42%
1 Month87.45109.03585.323495.56121,58213.2015.09%
3 Months94.43109.03582.3193.87173,9606.226.59%
6 Months100.52109.03582.3194.94167,4100.130.13%
1 Year150.77153.6082.31110.05209,379-50.12-33.24%
3 Years16.50325.9813.0886143.02172,80184.15510.0%
5 Years8.35325.986.60140.79159,14892.301,105.39%

Madrigal Pharmaceuticals Description

Madrigal Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular-metabolic diseases and non-alcoholic steatohepatitis (NASH). The product portfolio of the company includes MGL-3196, an orally administered, small-molecule liver-directed ß-selective THR agonist, which is used for the treatment of non-alcoholic steatohepatitis and familial hypercholesterolemia. In addition, MGL-3196 also reduces triglycerides in the plasma and liver by increasing fat metabolism and shows an anti-diabetic action.
Your Recent History
NASDAQ
MDGL
Madrigal P..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20191114 16:35:54